Brigit Biofarmaka Teknologi Tbk. vs Waran Seri II Panca Global Kapital Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Waran Seri II Panca Global Kapital Tbk. trades at Rp16 (market cap 13.22B, 77.42M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 12.5× Waran Seri II Panca Global Kapital Tbk.'s market cap, and Waran Seri II Panca Global Kapital Tbk. is more actively traded (77.42M versus 62.5K). Which is the better fit depends on your goals.
| OBAT | PEGE-W | |
|---|---|---|
Market Cap | 164.65B | 13.22B |
Volume | 62.5K | 77.42M |
Lot | 625 | 774.2K |
Turnover | 15.03M | 1.21B |
Average Price | 240.55 | 15.69 |
Value | 15.03M | 1.21B |
Indicative Equilibrium Price | 238 | 16 |
Indicative Equilibrium Volume | 100 | 12.33K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Panca Global Securities Tbk. (the Company) was established based on notarial deed No. 20 dated August 13th, 1999 of Fathiah Helmi, S.H., notary in Jakarta. The company's articles of association has been amended several times, and the latest amended on August 30, 2004 concerning company's plan for public offering. The company divides business into 2 divisions, stock brokerage and investment management division.
Read more on PEGE-W →